Infertility is the inability to get pregnant and is diagnosed after one year of carefully timed intercourse resulting in no pregnancy. In the United States, among heterosexual women aged 15 to 49 years with no prior births, about one in five are unable to get pregnant after one year of trying according to the Centers for Disease Control and Prevention. Infertility is not only a woman’s problem—both men and women can contribute to infertility.
Pieces of the Fertility Puzzle
UC Health’s mission is to provide advanced reproductive, endocrine and fertility care in a supportive, compassionate and patient-centered environment, using a personalized approach to provide comprehensive planning toward the diagnosis and treatment of gynecologic and fertility issues.
Every patient and couple are unique, and treatment plans are tailored to fit the specific needs for that individual patient or couple. From medications to minimally invasive procedures, plenty of options are available to help guide fertility journeys.
Your fertility depends on if you can ovulate. This is when an egg is released from an ovary. If you are not ovulating, you may be given hormone medicine to help.
Hormones are chemicals that your body makes naturally, and each type of hormone has its own function. In some cases, hormones are used for assisted reproductive technology (ART). Hormone medication can help:
- Make more eggs. Follicle-stimulating hormone (FSH) causes the ovaries to make more mature eggs each month. Normally, one egg matures each month naturally. Oral and injectable fertility medications are used to increase FSH and cause the ovaries to make multiple eggs within the same month.
- Trigger ovulation. Human chorionic gonadotropin (hCG) is used to cause ovulation. This can help by controlling the timing of when an egg can be fertilized after sex and may also be used for ART.
Ovulation induction (OI), or controlled ovarian hyperstimulation (COH), is often one of the first treatments recommended to patients and couples with fertility issues. Ovulation induction is the use of fertility medications to help stimulate the recruitment of egg(s) development and/or trigger ovulation. These medications can either be given orally (by mouth) or by injection. Pelvic ultrasound scans and blood tests to measure hormone levels assist with monitoring egg(s) development to determine when one is most fertile and likely to ovulate.
Intrauterine insemination (IUI) is the process of placing sperm into a woman’s uterus at the time that an egg is released from the ovary (ovulation). Sperm used during the IUI procedure are typically washed, and can either be obtained from the woman’s male partner or from a sperm donor. Washed sperm—or sperm that is separated from the fluid in which it swims (seminal fluid)—makes the sperm more mobile and increases the number of moving sperm within the reproductive tract. The greater the number of moving sperm means the greater the likelihood that sperm will locate an egg.
IUI is used for a variety of conditions, including male infertility, cervical or mucous problems, conditions that cause women not to release an egg, such as Polycystic ovary syndrome (PCOS) and unexplained infertility. For many patients and couples undergoing IUI, the use of hormone medications is needed and/or recommended to enhance a woman’s fertility.
In vitro fertilization
During the in-vitro fertilization (IVF) process, eggs are stimulated to grow with injectable fertility medications, removed from the ovaries by procedure and fertilized with sperm in the lab. The fertilized egg, or embryo, is later placed in the woman’s womb.
Jenn Wagner was 38 years old when she and her husband, Scott, married in October 2015. They immediately began trying to start their family, and after natural conception did not work for six months, Jenn sought treatment locally near her home in Wisconsin.
Jenn endured several rounds of intrauterine insemination (IUI), but after IUI failed, Jenn researched in-vitro fertilization (IVF).
Because her IVF treatment would be funded by her employer’s health plan, Jenn was given a short list of clinics to consider. The closest clinic to their home was the UC Health Center for Reproductive Health, with Suruchi S. Thakore, MD, medical director of in-vitro fertilization at UC Health and assistant professor in the Department of Obstetrics and Gynecology at the University of Cincinnati College of Medicine as her provider.
For many of our patients and couples, not being able to conceive despite various fertility treatments, is a challenging obstacle.
In late 2017, Jenn and Scott Wagner traveled from Wisconsin to UC Health’s West Chester Campus for the first time. Their visit ended with a plan for their first round of IVF to begin in early 2018. In August 2018 after four failed IVF attempts, Jenn believed it was clear that her body was not going to produce enough healthy eggs to create embryos.
The UC Health Center for Reproductive Health offers specialized third-party reproduction solutions for those individuals and couples who may benefit from egg/sperm donor or a gestational carrier’s assistance. According to the American Society for Reproductive Medicine, third party reproduction refers to the use of eggs, sperm or embryos that have been donated by a third person to enable an infertile individual or couple to become parents. The use of donor eggs, sperm or embryos can then be used in ART (assisted reproductive technology) procedures such as IUI and IVF. This also includes gestational carrier arrangements.
Another couple, Troy and Scott, always wanted to have kids, but they weren’t sure how to make that dream a reality.
“As a gay couple, our situation was unique,” they shared. To conceive, Troy and Scott needed the help of both an egg donor and gestational carrier.
While marching in the Cincinnati PRIDE Parade, they mentioned to their friend their desire to have kids. This friend later reached out to them, and they all met for dinner.
“She shared she felt she was meant to help us with our journey,” Scott shared, “and she offered to be our gestational carrier.”
A gestational carrier refers to a woman who agrees to have another individual’s or couple’s embryo(s) transferred into her uterus by way of IVF, and carries the pregnancy to term. The gestational carrier has no genetic link to the pregnancy she carries.
Highly recommended by friends, Scott and Troy reached out to Dr. Michael Thomas, chair of the Department of Obstetrics and Gynecology at UC Health and professor at the University of Cincinnati College of Medicine, for help. They sat down with Dr. Thomas, their questions were answered, and they were referred to the UC Health Center for Reproductive Health in West Chester.
Egg donation and gestational carrier
Their fertility journey initially began in late 2017, when Scott and Troy used an anonymous fresh-egg donor to create embryos using their sperm. Egg donation is when a woman elects to give her eggs to another individual or couple in the hopes of helping them become pregnant through in-vitro fertilization. Both egg donation and sperm donation, when a male voluntarily gives his sperm in the hopes of helping a woman or couple to become pregnant, can be done anonymously or as a directed (known) donor.
Egg donation assists individuals who otherwise are not able to conceive and/or those who may suffer or have experienced the following:
- Natural menopause.
- Surgically induced menopause.
- Chemotherapy or radiation-induced menopause.
- Premature ovarian failure.
- Poor quality eggs.
- Repetitive failure with IVF.
- Individuals who carry genetic abnormalities or genetically transmitted disease.
The initial journey for Troy and Scott was tough, having to synchronize the egg donor and their friend Stephanie’s cycles. By administering specific hormones to start both menstrual cycles at the same time, the lining of the recipient’s uterus is ready to receive the embryos created and nourish them.
“We transferred the first embryo in February 2018 and our beautiful baby girl was born in October,” Scott and Troy shared.